3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Neoplasms
3
Lung Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Endometrial Neoplasms
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligomenorrhea
1
Menstruation Disturbances
1
Kidney Neoplasms
1
Infertility
1
Hyperandrogenism
1
Hirsutism
1
Hip Fractures
1
Hepatic Veno-Occlusive Disease
1
HCC
1
Fibrosis
1
Fatigue
1
Endocrine System Diseases
1
Disease
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anovulation
1
Interventions
Cyclophosphamide
37
Cytarabine
27
Methotrexate
22
Dexamethasone
20
Vincristine
19
fludarabine
15
Mercaptopurine
14
Etoposide
14
Radiotherapy
12
Daunorubicin
12
Asparaginase
12
Doxorubicin
11
Prednisolone
9
Idarubicin
9
Busulfan
8
pegaspargase
7
blinatumomab
7
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Immunotherapy, Adoptive
6
Imatinib Mesylate
6
Dasatinib
6
fludarabine phosphate
5
Prednisone
5
Methylprednisolone
5
Filgrastim
5
Whole-Body Irradiation
4
Thioguanine
4
Rituximab
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Hematologic Tests
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled